Showing results (51-60 of 58) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
American Journal of Human Genetics|November 24, 2001
Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiencyAndreas Holzinger, Esther M Maier, Cornelius Bück, et al.Nature Structural & Molecular Biology|December 6, 2016
Warfarin traps human vitamin K epoxide reductase in an intermediate state during electron transferGuomin Shen, Weidong Cui, Hao Zhang, et al.Blood|March 21, 1998
Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to plateletsC A Hillery, D J Mancuso, J Evan Sadler, et al.American Journal of Hematology|May 6, 2009
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelinesWilliam L Nichols, Margaret E Rick, Thomas L Ortel, et al.Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Allosteric activation of ADAMTS13 by von Willebrand factorJoshua Muia, Jian Zhu, Garima Gupta, et al.Journal of the American College of Cardiology|September 18, 2007
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR ProjectCharles L Bennett, Benjamin Kim, Anaadriana Zakarija, et al.Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.Pageof 6